NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

心房中膈缺損症的全球市場:症狀的預測(到2025年)- COVID-19累積的影響

Atrial Septal Defect Market Research Report by Symptoms (Dyspnea, Fatigue, and Frequent Respiratory Infections), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版商 360iResearch LLP 商品編碼 1001150
出版日期 內容資訊 英文 189 Pages
商品交期: 最快1-2個工作天內
價格
心房中膈缺損症的全球市場:症狀的預測(到2025年)- COVID-19累積的影響 Atrial Septal Defect Market Research Report by Symptoms (Dyspnea, Fatigue, and Frequent Respiratory Infections), by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19
出版日期: 2021年06月01日內容資訊: 英文 189 Pages
簡介

全球心房中膈缺損症的市場規模預測將從2020年的47億9,067萬美元擴大到2025年末的61億9,056萬美元。

COVID-19是前所未有的全球性公共衛生突發事件,已影響到每個行業。這種長期影響預計將在預測期內影響行業增長。我們正在進行的研究正在擴大我們的研究範圍,以確保我們窮究潛在的COVID-19問題和未來路徑。該報告考慮了消費者行為和需求的變化,購買方式,供應鏈的重新改道,當前市場趨勢以及政府的重要介入等因素,提供有關COVID-19的洞察。

本報告提供全球心房中膈缺損症市場的相關調查,提供市場機會和課題,成長及阻礙因素,COVID-19累積的影響,症狀·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 序文

  • 調查的目的
  • 市場區隔和涵蓋範圍
  • 調查期間
  • 貨幣和價格
  • 語言
  • 限制事項
  • 利害關係者

第2章 調查手法

  • 調查流程
    • 定義:調查目的
    • 決策:調查設計
    • 準備:調查設備
    • 收集:資料來源
    • 分析:資料的解釋
    • 制定:資料檢驗
    • 公開:調查報告
    • 重複:報告的更新
  • 調查的實行
    • 開始:調查流程
    • 製作計劃:調查計劃
    • 實施實行:調查
    • 檢驗:發現與分析
    • 出版物:調查報告
  • 調查的成果

第3章 摘要整理

  • 市場展望
  • 不同症狀市場展望
  • 各地區市場的展望
  • 其他競爭公司預測

第4章 市場概要

  • COVID-19累積的影響

第5章 市場洞察

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
    • 課題
  • 波特的五力分析

第6章 不同症狀市場

  • 呼吸困難
  • 倦怠感
  • 反復性呼吸系統感染疾病
  • 心跳
  • 下肢腫脹

第7章 南北美洲市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第8章 亞太地區市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 韓國
  • 泰國

第9章 歐洲,中東·非洲市場

  • 法國
  • 德國
  • 義大利
  • 荷蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 阿拉伯聯合大公國
  • 英國

第10章 競爭情形

  • FPNV定位矩陣
    • 象限
    • 事業策略
    • 產品的滿意度
  • 市場排行榜分析
  • 市場佔有率分析
  • 其他競爭公司的SWOT分析
  • 競爭模式
    • 合併·收購
    • 協定,合作,及夥伴關係
    • 新產品的銷售與強化
    • 投資與資金籌措
    • 評估,認識,擴大

第11章 企業簡介

  • Abbott Laboratories
  • Actelion Ltd
  • Asklepion Pharmaceuticals, LLC
  • AtriCure, Inc
  • Biosense Webster, Inc.
  • Boston Scientific Corporation
  • Carag AG
  • Comed B.V.
  • Edwards Lifesciences
  • GE Healthcare
  • INO Therapeutics, LLC
  • Lepu Medical Technology (Beijing) Co., Ltd
  • Lifetech Scientific
  • Mallow Primary Healthcare Centre
  • Medtronic PLC
  • MicroPort Scientific Corp
  • Novo Nordisk A/S
  • Numed, Inc.
  • Occlutech GmbH
  • pfm medical AG
  • Siemens Healthineers AG
  • St. Jude Medical, Inc
  • Toshiba Corporation
  • W. L. Gore & Associates, Inc.

第12章 附錄

  • 討論指南
  • 許可證和價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MRR-CA17E905E9D5

The Global Atrial Septal Defect Market size was estimated at USD 4,790.67 Million in 2020 and expected to reach USD 5,066.65 Million in 2021, at a Compound Annual Growth Rate (CAGR) 6.09% to reach USD 6,833.91 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Atrial Septal Defect to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Symptoms , the Atrial Septal Defect Market was studied across Dyspnea, Fatigue, Frequent Respiratory Infections, Heart Palpitations, and Swelling Of Legs And Feet.

Based on Geography, the Atrial Septal Defect Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Atrial Septal Defect Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Atrial Septal Defect Market, including Abbott Laboratories, Actelion Ltd, Asklepion Pharmaceuticals, LLC, AtriCure, Inc, Biosense Webster, Inc., Boston Scientific Corporation, Carag AG, Comed B.V., Edwards Lifesciences, GE Healthcare, INO Therapeutics, LLC, Lepu Medical Technology (Beijing) Co., Ltd, Lifetech Scientific, Mallow Primary Healthcare Centre, Medtronic PLC, MicroPort Scientific Corp, Novo Nordisk A/S, Numed, Inc., Occlutech GmbH, pfm medical AG, Siemens Healthineers AG, St. Jude Medical, Inc, Toshiba Corporation, and W. L. Gore & Associates, Inc..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Atrial Septal Defect Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Atrial Septal Defect Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Atrial Septal Defect Market?
  • 4. What is the competitive strategic window for opportunities in the Global Atrial Septal Defect Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Atrial Septal Defect Market?
  • 6. What is the market share of the leading vendors in the Global Atrial Septal Defect Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Atrial Septal Defect Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Symptoms Outlook
  • 3.4. Geography Outlook
  • 3.5. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of genetic heart disorders
      • 5.1.1.2. Growing awareness regarding atrial septal defects among the population
      • 5.1.1.3. Adoption of MRI procedures
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the devices to carry out the procedure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the treatment of congenital heart diseases
      • 5.1.3.2. Favorable government reimbursements and growing disposable income
    • 5.1.4. Challenges
      • 5.1.4.1. Heart defect closure device-related limitations
      • 5.1.4.2. Possible risk factors for erosion after ASD closure with the Amplatzer septal occluder device
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Atrial Septal Defect Market, by Symptoms

  • 6.1. Introduction
  • 6.2. Dyspnea
  • 6.3. Fatigue
  • 6.4. Frequent Respiratory Infections
  • 6.5. Heart Palpitations
  • 6.6. Swelling Of Legs And Feet

7. Americas Atrial Septal Defect Market

  • 7.1. Introduction
  • 7.2. Argentina
  • 7.3. Brazil
  • 7.4. Canada
  • 7.5. Mexico
  • 7.6. United States
    • 7.6.1. California
    • 7.6.2. Florida
    • 7.6.3. Illinois
    • 7.6.4. New York
    • 7.6.5. Ohio
    • 7.6.6. Pennsylvania
    • 7.6.7. Texas

8. Asia-Pacific Atrial Septal Defect Market

  • 8.1. Introduction
  • 8.2. China
  • 8.3. India
  • 8.4. Indonesia
  • 8.5. Japan
  • 8.6. Malaysia
  • 8.7. Philippines
  • 8.8. South Korea
  • 8.9. Thailand

9. Europe, Middle East & Africa Atrial Septal Defect Market

  • 9.1. Introduction
  • 9.2. France
  • 9.3. Germany
  • 9.4. Italy
  • 9.5. Netherlands
  • 9.6. Qatar
  • 9.7. Russia
  • 9.8. Saudi Arabia
  • 9.9. South Africa
  • 9.10. Spain
  • 9.11. United Arab Emirates
  • 9.12. United Kingdom

10. Competitive Landscape

  • 10.1. FPNV Positioning Matrix
    • 10.1.1. Quadrants
    • 10.1.2. Business Strategy
    • 10.1.3. Product Satisfaction
  • 10.2. Market Ranking Analysis
  • 10.3. Market Share Analysis, By Quadrant
  • 10.4. Market Share Analysis, By Company
  • 10.5. Competitive Scenario
    • 10.5.1. Merger & Acquisition
    • 10.5.2. Agreement, Collaboration, & Partnership
    • 10.5.3. New Product Launch & Enhancement
    • 10.5.4. Investment & Funding
    • 10.5.5. Award, Recognition, & Expansion

11. Company Usability Profiles

  • 11.1. Abbott Laboratories
  • 11.2. Actelion Ltd
  • 11.3. Asklepion Pharmaceuticals, LLC
  • 11.4. AtriCure, Inc
  • 11.5. Biosense Webster, Inc.
  • 11.6. Boston Scientific Corporation
  • 11.7. Carag AG
  • 11.8. Comed B.V.
  • 11.9. Edwards Lifesciences
  • 11.10. GE Healthcare
  • 11.11. INO Therapeutics, LLC
  • 11.12. Lepu Medical Technology (Beijing) Co., Ltd
  • 11.13. Lifetech Scientific
  • 11.14. Mallow Primary Healthcare Centre
  • 11.15. Medtronic PLC
  • 11.16. MicroPort Scientific Corp
  • 11.17. Novo Nordisk A/S
  • 11.18. Numed, Inc.
  • 11.19. Occlutech GmbH
  • 11.20. pfm medical AG
  • 11.21. Siemens Healthineers AG
  • 11.22. St. Jude Medical, Inc
  • 11.23. Toshiba Corporation
  • 11.24. W. L. Gore & Associates, Inc.

12. Appendix

  • 12.1. Discussion Guide
  • 12.2. License & Pricing
  • 12.3. Contact Details

LIST OF FIGURES

  • FIGURE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2020 (USD MILLION)
  • FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET: MARKET DYNAMICS
  • FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2020 VS 2026 (%)
  • FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2020 VS 2026 (USD MILLION)
  • FIGURE 8. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2026
  • FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, 2018-2026 (USD MILLION)
  • FIGURE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, 2018-2026 (USD MILLION)
  • FIGURE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS AND FEET, 2018-2026 (USD MILLION)
  • FIGURE 18. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS AND FEET, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 19. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 20. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 22. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 23. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 24. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 25. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 26. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 27. CALIFORNIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 28. FLORIDA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 29. ILLINOIS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 30. NEW YORK ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 31. OHIO ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 32. PENNSYLVANIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 33. TEXAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 34. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 35. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 37. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 38. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 39. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 40. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 46. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 48. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 53. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 54. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 55. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. GLOBAL ATRIAL SEPTAL DEFECT MARKET: FPNV POSITIONING MATRIX
  • FIGURE 60. GLOBAL ATRIAL SEPTAL DEFECT MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 61. GLOBAL ATRIAL SEPTAL DEFECT MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 62. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL ATRIAL SEPTAL DEFECT MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL ATRIAL SEPTAL DEFECT MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS AND FEET, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. CALIFORNIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. FLORIDA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. ILLINOIS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. NEW YORK ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. OHIO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. PENNSYLVANIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. TEXAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS , 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. GLOBAL ATRIAL SEPTAL DEFECT MARKET: SCORES
  • TABLE 48. GLOBAL ATRIAL SEPTAL DEFECT MARKET: BUSINESS STRATEGY
  • TABLE 49. GLOBAL ATRIAL SEPTAL DEFECT MARKET: PRODUCT SATISFACTION
  • TABLE 50. GLOBAL ATRIAL SEPTAL DEFECT MARKET: RANKING
  • TABLE 51. GLOBAL ATRIAL SEPTAL DEFECT MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 52. GLOBAL ATRIAL SEPTAL DEFECT MARKET: SHARE, BY COMPANY, 2020
  • TABLE 53. GLOBAL ATRIAL SEPTAL DEFECT MARKET: MERGER & ACQUISITION
  • TABLE 54. GLOBAL ATRIAL SEPTAL DEFECT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 55. GLOBAL ATRIAL SEPTAL DEFECT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 56. GLOBAL ATRIAL SEPTAL DEFECT MARKET: INVESTMENT & FUNDING
  • TABLE 57. GLOBAL ATRIAL SEPTAL DEFECT MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 58. GLOBAL ATRIAL SEPTAL DEFECT MARKET: LICENSE & PRICING
  • TABLE 59. GLOBAL ATRIAL SEPTAL DEFECT MARKET: CONTACT DETAILS